PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1403513
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1403513
Paronychia Treatment Market Forecasts to 2030 - Global Analysis By Product, Type, End User and By Geography
According to Stratistics MRC, the Global Paronychia Treatment Market is accounted for $507.34 million in 2023 and is expected to reach $939.42 million by 2030 growing at a CAGR of 9.2% during the forecast period. Paronychia is a common nail infection characterized by inflammation of the skin surrounding the fingernail or toenail. This is caused by bacteria, fungi, or both, leading to redness, swelling, and pain. Treatment involves warm soaks, proper wound drainage, topical or oral antibiotics for bacterial infections, antifungal medications for fungal cases, and in severe or recurrent instances, surgical intervention may be necessary.
Market Dynamics:
Driver:
Significant rise in diabetes patients
Diabetic individuals are more susceptible to nail infections like paronychia due to compromised immune systems, nerve damage, and reduced blood circulation, making them susceptible to bacterial or fungal nail infections. With the escalating, global diabetes prevalence, there's been a corresponding increase in the incidence of diabetic-related complications, including nail disorders. Diabetic patients often experience challenges in managing infections, necessitating prompt and effective treatment for paronychia.
Restraint:
Counterfeit medications
Counterfeit or unregulated medications pose a serious threat, potentially offering ineffective, substandard, or even harmful treatments to individuals seeking remedies for paronychia. Such unauthorized drugs lack quality control, proper efficacy, and safety standards, raising concerns among healthcare professionals and patients about treatment reliability and potential adverse effects. The presence of these illegitimate products undermines trust in the market's offerings, hindering the market's growth.
Opportunity:
Advancements in technology
Innovative technologies offer improved drug formulations, targeted delivery systems, and enhanced diagnostic tools. Nanotechnology, transdermal patches, and sophisticated imaging or molecular testing enable more effective and precise treatment approaches. Additionally, telemedicine facilitates remote consultations, expanding access to specialized care. These technological advancements enhance treatment efficacy, patient experience, and the overall landscape of paronychia treatments, fostering opportunities for innovation and growth within the market.
Threat:
Limited awareness
Insufficient knowledge among individuals about paronychia, its symptoms, and the importance of seeking timely medical care may result in delayed diagnosis and treatment. Lack of awareness about preventive measures and available treatment options could hinder early intervention, leading to the progression of nail infections. This limited awareness impacts market growth by reducing the patient pool and impeding the adoption of effective paronychia treatments.
COVID-19 Impact
The deadly corona virus spread quickly around the world, overwhelming hospitals, redirecting resources, and restricting access to non-essential medical services. This caused major disruptions in healthcare systems that impacted paronychia diagnosis, treatment, and management, as well as delayed or decreased access to healthcare services. In order to get their problems resolved those who are experiencing infections and adverse consequences, including pain and inflammation, must wait for the services to resume.
The chronic paronychia segment is expected to be the largest during the forecast period
The chronic paronychia segment is estimated to hold the largest share. Chronic paronychia is a long-term condition that often arises from fungal or bacterial infections, irritants, or predisposing factors such as repetitive trauma or underlying health conditions. Treatments for chronic paronychia include topical antifungal or antibiotic medications, oral therapies, warm soaks, and preventive measures addressing potential irritants. Moreover, chronic paronychia requires long-term, specialised therapy due to its recurrent nature. As a result, there is a dedicated market focus on treating this type of illness.
The gentamicin ointment segment is expected to have the highest CAGR during the forecast period
The gentamicin ointment segment is anticipated to have lucrative growth during the forecast period. Gentamicin ointment contains gentamicin, an antibiotic effective against a wide range of bacteria. Applied directly to the affected nail area, gentamicin ointment targets bacterial infections, reducing inflammation and promoting healing. Furthermore, its localised application and antibacterial properties make it a valuable treatment option for mild-to-moderate bacterial paronychia cases. This segment caters specifically to individuals requiring targeted antimicrobial therapy, contributing to the market's array of topical treatments for addressing bacterial nail infections like paronychia.
Region with largest share:
Asia Pacific commanded the largest market share during the extrapolated period due to increasing healthcare awareness, a rising prevalence of nail infections, and improving healthcare infrastructure. The region's diverse population and changing lifestyles contribute to the growing incidence of paronychia. Moreover, due to the increased population base suffering from paronychia and their rising spending on the treatment of this issue, and the surging prevalence of favourable government initiatives aimed at improving healthcare infrastructure and promoting awareness about nail infections, this is driving the demand for market growth.
Region with highest CAGR:
North America is expected to witness profitable growth over the projection period due to a surge in the geriatric population, growing people's knowledge of viable treatments, and the robust presence of major market players in countries like the US and Canada. Moreover, the quick development of cutting-edge paronychia treatment alternatives, such as new topical therapies, antifungal medications, and antibiotics, which have increased the variety of treatment methods offered in clinics and hospitals, is likely to impact the market positively.
Key players in the market:
Some of the key players in the Paronychia Treatment Market include Glenmark Generics Ltd, Eli Lilly Company, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd, Jonakayem Pharma Formulation, Fougera Pharmaceuticals Inc, Allergen Plc, Johnson & Johnson Services Inc., Bayer AG, Merck & Co. Inc., Perrigo New York Inc., Novartis AG, Pfizer Inc., Taro Pharmaceutical Industries and Sandoz International GmbH.
Key Developments:
In January 2023, The National Medical Products Administration of China announced that they have approved the mobocertinib for treatment of the adult patients with advanced and metastatic non-small lung cancer. The newly developed treatment technique was mostly experienced with mobocertinib including paronychia, diarrhoea, rash, and decreased appetite.
Products Covered:
- Mupirocin Ointment
- Gentamicin Ointment
- Fusidic Acid Ointment
- Dicloxacillin
- Other Products
Types Covered:
- Chronic Paronychia
- Acute Paronychia
- Pyogenic Paronychia
- Candidal Paronychia
- Other Types
End Users Covered:
- Dermatology Centers
- Hospitals & Clinics
- Other End Users
Regions Covered:
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
- South America
- Argentina
- Brazil
- Chile
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
- Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
- Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
- Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
- 2.1 Abstract
- 2.2 Stake Holders
- 2.3 Research Scope
- 2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
- 2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions
3 Market Trend Analysis
- 3.1 Introduction
- 3.2 Drivers
- 3.3 Restraints
- 3.4 Opportunities
- 3.5 Threats
- 3.6 Product Analysis
- 3.7 End User Analysis
- 3.8 Emerging Markets
- 3.9 Impact of Covid-19
4 Porters Five Force Analysis
- 4.1 Bargaining power of suppliers
- 4.2 Bargaining power of buyers
- 4.3 Threat of substitutes
- 4.4 Threat of new entrants
- 4.5 Competitive rivalry
5 Global Paronychia Treatment Market, By Product
- 5.1 Introduction
- 5.2 Mupirocin Ointment
- 5.3 Gentamicin Ointment
- 5.4 Fusidic Acid Ointment
- 5.5 Dicloxacillin
- 5.6 Other Products
6 Global Paronychia Treatment Market, By Type
- 6.1 Introduction
- 6.2 Chronic Paronychia
- 6.3 Acute Paronychia
- 6.4 Pyogenic Paronychia
- 6.5 Candidal Paronychia
- 6.6 Other Types
7 Global Paronychia Treatment Market, By End User
- 7.1 Introduction
- 7.2 Dermatology Centers
- 7.3 Hospitals & Clinics
- 7.4 Other End Users
8 Global Paronychia Treatment Market, By Geography
- 8.1 Introduction
- 8.2 North America
- 8.2.1 US
- 8.2.2 Canada
- 8.2.3 Mexico
- 8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 Italy
- 8.3.4 France
- 8.3.5 Spain
- 8.3.6 Rest of Europe
- 8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 New Zealand
- 8.4.6 South Korea
- 8.4.7 Rest of Asia Pacific
- 8.5 South America
- 8.5.1 Argentina
- 8.5.2 Brazil
- 8.5.3 Chile
- 8.5.4 Rest of South America
- 8.6 Middle East & Africa
- 8.6.1 Saudi Arabia
- 8.6.2 UAE
- 8.6.3 Qatar
- 8.6.4 South Africa
- 8.6.5 Rest of Middle East & Africa
9 Key Developments
- 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
- 9.2 Acquisitions & Mergers
- 9.3 New Product Launch
- 9.4 Expansions
- 9.5 Other Key Strategies
10 Company Profiling
- 10.1 Glenmark Generics Ltd
- 10.2 Eli Lilly Company
- 10.3 GlaxoSmithKline plc
- 10.4 Teva Pharmaceutical Industries Ltd
- 10.5 Jonakayem Pharma Formulation
- 10.6 Fougera Pharmaceuticals Inc
- 10.7 Allergen Plc
- 10.8 Johnson & Johnson Services Inc.
- 10.9 Bayer AG
- 10.10 Merck & Co. Inc.
- 10.11 Perrigo New York Inc.
- 10.12 Novartis AG
- 10.13 Pfizer Inc.
- 10.14 Taro Pharmaceutical Industries
- 10.15 Sandoz International GmbH
List of Tables
- Table 1 Global Paronychia Treatment Market Outlook, By Region (2021-2030) ($MN)
- Table 2 Global Paronychia Treatment Market Outlook, By Product (2021-2030) ($MN)
- Table 3 Global Paronychia Treatment Market Outlook, By Mupirocin Ointment (2021-2030) ($MN)
- Table 4 Global Paronychia Treatment Market Outlook, By Gentamicin Ointment (2021-2030) ($MN)
- Table 5 Global Paronychia Treatment Market Outlook, By Fusidic Acid Ointment (2021-2030) ($MN)
- Table 6 Global Paronychia Treatment Market Outlook, By Dicloxacillin (2021-2030) ($MN)
- Table 7 Global Paronychia Treatment Market Outlook, By Other Products (2021-2030) ($MN)
- Table 8 Global Paronychia Treatment Market Outlook, By Type (2021-2030) ($MN)
- Table 9 Global Paronychia Treatment Market Outlook, By Chronic Paronychia (2021-2030) ($MN)
- Table 10 Global Paronychia Treatment Market Outlook, By Acute Paronychia (2021-2030) ($MN)
- Table 11 Global Paronychia Treatment Market Outlook, By Pyogenic Paronychia (2021-2030) ($MN)
- Table 12 Global Paronychia Treatment Market Outlook, By Candidal Paronychia (2021-2030) ($MN)
- Table 13 Global Paronychia Treatment Market Outlook, By Other Types (2021-2030) ($MN)
- Table 14 Global Paronychia Treatment Market Outlook, By End User (2021-2030) ($MN)
- Table 15 Global Paronychia Treatment Market Outlook, By Dermatology Centers (2021-2030) ($MN)
- Table 16 Global Paronychia Treatment Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
- Table 17 Global Paronychia Treatment Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 18 North America Paronychia Treatment Market Outlook, By Country (2021-2030) ($MN)
- Table 19 North America Paronychia Treatment Market Outlook, By Product (2021-2030) ($MN)
- Table 20 North America Paronychia Treatment Market Outlook, By Mupirocin Ointment (2021-2030) ($MN)
- Table 21 North America Paronychia Treatment Market Outlook, By Gentamicin Ointment (2021-2030) ($MN)
- Table 22 North America Paronychia Treatment Market Outlook, By Fusidic Acid Ointment (2021-2030) ($MN)
- Table 23 North America Paronychia Treatment Market Outlook, By Dicloxacillin (2021-2030) ($MN)
- Table 24 North America Paronychia Treatment Market Outlook, By Other Products (2021-2030) ($MN)
- Table 25 North America Paronychia Treatment Market Outlook, By Type (2021-2030) ($MN)
- Table 26 North America Paronychia Treatment Market Outlook, By Chronic Paronychia (2021-2030) ($MN)
- Table 27 North America Paronychia Treatment Market Outlook, By Acute Paronychia (2021-2030) ($MN)
- Table 28 North America Paronychia Treatment Market Outlook, By Pyogenic Paronychia (2021-2030) ($MN)
- Table 29 North America Paronychia Treatment Market Outlook, By Candidal Paronychia (2021-2030) ($MN)
- Table 30 North America Paronychia Treatment Market Outlook, By Other Types (2021-2030) ($MN)
- Table 31 North America Paronychia Treatment Market Outlook, By End User (2021-2030) ($MN)
- Table 32 North America Paronychia Treatment Market Outlook, By Dermatology Centers (2021-2030) ($MN)
- Table 33 North America Paronychia Treatment Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
- Table 34 North America Paronychia Treatment Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 35 Europe Paronychia Treatment Market Outlook, By Country (2021-2030) ($MN)
- Table 36 Europe Paronychia Treatment Market Outlook, By Product (2021-2030) ($MN)
- Table 37 Europe Paronychia Treatment Market Outlook, By Mupirocin Ointment (2021-2030) ($MN)
- Table 38 Europe Paronychia Treatment Market Outlook, By Gentamicin Ointment (2021-2030) ($MN)
- Table 39 Europe Paronychia Treatment Market Outlook, By Fusidic Acid Ointment (2021-2030) ($MN)
- Table 40 Europe Paronychia Treatment Market Outlook, By Dicloxacillin (2021-2030) ($MN)
- Table 41 Europe Paronychia Treatment Market Outlook, By Other Products (2021-2030) ($MN)
- Table 42 Europe Paronychia Treatment Market Outlook, By Type (2021-2030) ($MN)
- Table 43 Europe Paronychia Treatment Market Outlook, By Chronic Paronychia (2021-2030) ($MN)
- Table 44 Europe Paronychia Treatment Market Outlook, By Acute Paronychia (2021-2030) ($MN)
- Table 45 Europe Paronychia Treatment Market Outlook, By Pyogenic Paronychia (2021-2030) ($MN)
- Table 46 Europe Paronychia Treatment Market Outlook, By Candidal Paronychia (2021-2030) ($MN)
- Table 47 Europe Paronychia Treatment Market Outlook, By Other Types (2021-2030) ($MN)
- Table 48 Europe Paronychia Treatment Market Outlook, By End User (2021-2030) ($MN)
- Table 49 Europe Paronychia Treatment Market Outlook, By Dermatology Centers (2021-2030) ($MN)
- Table 50 Europe Paronychia Treatment Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
- Table 51 Europe Paronychia Treatment Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 52 Asia Pacific Paronychia Treatment Market Outlook, By Country (2021-2030) ($MN)
- Table 53 Asia Pacific Paronychia Treatment Market Outlook, By Product (2021-2030) ($MN)
- Table 54 Asia Pacific Paronychia Treatment Market Outlook, By Mupirocin Ointment (2021-2030) ($MN)
- Table 55 Asia Pacific Paronychia Treatment Market Outlook, By Gentamicin Ointment (2021-2030) ($MN)
- Table 56 Asia Pacific Paronychia Treatment Market Outlook, By Fusidic Acid Ointment (2021-2030) ($MN)
- Table 57 Asia Pacific Paronychia Treatment Market Outlook, By Dicloxacillin (2021-2030) ($MN)
- Table 58 Asia Pacific Paronychia Treatment Market Outlook, By Other Products (2021-2030) ($MN)
- Table 59 Asia Pacific Paronychia Treatment Market Outlook, By Type (2021-2030) ($MN)
- Table 60 Asia Pacific Paronychia Treatment Market Outlook, By Chronic Paronychia (2021-2030) ($MN)
- Table 61 Asia Pacific Paronychia Treatment Market Outlook, By Acute Paronychia (2021-2030) ($MN)
- Table 62 Asia Pacific Paronychia Treatment Market Outlook, By Pyogenic Paronychia (2021-2030) ($MN)
- Table 63 Asia Pacific Paronychia Treatment Market Outlook, By Candidal Paronychia (2021-2030) ($MN)
- Table 64 Asia Pacific Paronychia Treatment Market Outlook, By Other Types (2021-2030) ($MN)
- Table 65 Asia Pacific Paronychia Treatment Market Outlook, By End User (2021-2030) ($MN)
- Table 66 Asia Pacific Paronychia Treatment Market Outlook, By Dermatology Centers (2021-2030) ($MN)
- Table 67 Asia Pacific Paronychia Treatment Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
- Table 68 Asia Pacific Paronychia Treatment Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 69 South America Paronychia Treatment Market Outlook, By Country (2021-2030) ($MN)
- Table 70 South America Paronychia Treatment Market Outlook, By Product (2021-2030) ($MN)
- Table 71 South America Paronychia Treatment Market Outlook, By Mupirocin Ointment (2021-2030) ($MN)
- Table 72 South America Paronychia Treatment Market Outlook, By Gentamicin Ointment (2021-2030) ($MN)
- Table 73 South America Paronychia Treatment Market Outlook, By Fusidic Acid Ointment (2021-2030) ($MN)
- Table 74 South America Paronychia Treatment Market Outlook, By Dicloxacillin (2021-2030) ($MN)
- Table 75 South America Paronychia Treatment Market Outlook, By Other Products (2021-2030) ($MN)
- Table 76 South America Paronychia Treatment Market Outlook, By Type (2021-2030) ($MN)
- Table 77 South America Paronychia Treatment Market Outlook, By Chronic Paronychia (2021-2030) ($MN)
- Table 78 South America Paronychia Treatment Market Outlook, By Acute Paronychia (2021-2030) ($MN)
- Table 79 South America Paronychia Treatment Market Outlook, By Pyogenic Paronychia (2021-2030) ($MN)
- Table 80 South America Paronychia Treatment Market Outlook, By Candidal Paronychia (2021-2030) ($MN)
- Table 81 South America Paronychia Treatment Market Outlook, By Other Types (2021-2030) ($MN)
- Table 82 South America Paronychia Treatment Market Outlook, By End User (2021-2030) ($MN)
- Table 83 South America Paronychia Treatment Market Outlook, By Dermatology Centers (2021-2030) ($MN)
- Table 84 South America Paronychia Treatment Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
- Table 85 South America Paronychia Treatment Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 86 Middle East & Africa Paronychia Treatment Market Outlook, By Country (2021-2030) ($MN)
- Table 87 Middle East & Africa Paronychia Treatment Market Outlook, By Product (2021-2030) ($MN)
- Table 88 Middle East & Africa Paronychia Treatment Market Outlook, By Mupirocin Ointment (2021-2030) ($MN)
- Table 89 Middle East & Africa Paronychia Treatment Market Outlook, By Gentamicin Ointment (2021-2030) ($MN)
- Table 90 Middle East & Africa Paronychia Treatment Market Outlook, By Fusidic Acid Ointment (2021-2030) ($MN)
- Table 91 Middle East & Africa Paronychia Treatment Market Outlook, By Dicloxacillin (2021-2030) ($MN)
- Table 92 Middle East & Africa Paronychia Treatment Market Outlook, By Other Products (2021-2030) ($MN)
- Table 93 Middle East & Africa Paronychia Treatment Market Outlook, By Type (2021-2030) ($MN)
- Table 94 Middle East & Africa Paronychia Treatment Market Outlook, By Chronic Paronychia (2021-2030) ($MN)
- Table 95 Middle East & Africa Paronychia Treatment Market Outlook, By Acute Paronychia (2021-2030) ($MN)
- Table 96 Middle East & Africa Paronychia Treatment Market Outlook, By Pyogenic Paronychia (2021-2030) ($MN)
- Table 97 Middle East & Africa Paronychia Treatment Market Outlook, By Candidal Paronychia (2021-2030) ($MN)
- Table 98 Middle East & Africa Paronychia Treatment Market Outlook, By Other Types (2021-2030) ($MN)
- Table 99 Middle East & Africa Paronychia Treatment Market Outlook, By End User (2021-2030) ($MN)
- Table 100 Middle East & Africa Paronychia Treatment Market Outlook, By Dermatology Centers (2021-2030) ($MN)
- Table 101 Middle East & Africa Paronychia Treatment Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
- Table 102 Middle East & Africa Paronychia Treatment Market Outlook, By Other End Users (2021-2030) ($MN)
